JW (CAYMAN) THERAPEUTICS CO. LTD earnings per share and revenue

2126 earnings per share for the last semiannual are -0.62 HKD whereas the estimation was -0.69 HKD which accounts for 9.38% surprise. Company revenue for the same period amounts to 93.28 M HKD despite the estimated figure of 115.74 M HKD. Estimated earnings per share for the next semiannual are -0.71 HKD, and revenue is expected to reach 141.60 M HKD. Also watch annual changes over time to get a bigger picture of 2126 earnings per share and revenue dynamics.